Cargando…
Hepatic artery infusion with raltitrexed or 5-fluorouracil for colorectal cancer liver metastasis
AIM: To evaluate the efficiency and safety of hepatic artery infusion chemotherapy (HAIC) using raltitrexed or 5-fluorouracil for colorectal cancer (CRC) liver metastasis (CRCLM). METHODS: A retrospective analysis of patients with unresectable CRCLM who failed systemic chemotherapy and were subseque...
Autores principales: | Guo, Jian-Hai, Zhang, Hang-Yu, Gao, Song, Zhang, Peng-Jun, Li, Xiao-Ting, Chen, Hui, Wang, Xiao-Dong, Zhu, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330825/ https://www.ncbi.nlm.nih.gov/pubmed/28293087 http://dx.doi.org/10.3748/wjg.v23.i8.1406 |
Ejemplares similares
-
Transarterial embolization and low-dose continuous hepatic arterial infusion chemotherapy with oxaliplatin and raltitrexed for hepatocellular carcinoma with major portal vein tumor thrombus
por: Zhu, Lin-Zhong, et al.
Publicado: (2018) -
Effect of primary tumor side on survival outcomes in metastatic colorectal cancer patients after hepatic arterial infusion chemotherapy
por: Zhang, Hang-Yu, et al.
Publicado: (2018) -
Prognostic factors of survival and a new scoring system for liver resection of colorectal liver metastasis
por: Cheng, Kai-Chi, et al.
Publicado: (2022) -
A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastases
por: Feng, Ai-Wei, et al.
Publicado: (2022) -
No long-term survival benefit with sustained-release 5-fluorouracil implants in patients with stages II and III gastric cancer
por: Wu, Yun-Zi, et al.
Publicado: (2022)